News

News

Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

TAMPA, Fla., July 29, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,

July 29, 2020Read More
Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

TAMPA, Fla., June 16, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,

June 16, 2020Read More
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

Merger Establishes US and EMEA Presence for the Preeminent Chinese Structural Heart Company HANGZHOU, China and CAESAREA, Israel and TAMPA, Florida

January 09, 2019Read More
Current Cerebral Embolic Protection Landscape

Current Cerebral Embolic Protection Landscape

Keystone Heart TriGUARD Data ReviewJeffrey MosesConclusions:Overt and Covert stroke are significant complications of TAVR which may be o

December 03, 2018Read More
REFLECT Clinical Update with TriGUARD3 Cerebral Embolic Protection Device

REFLECT Clinical Update with TriGUARD3 Cerebral Embolic Protection Device

Tamim NazifConclusions:TriGUARD 3™ offers complete 3 vessel cerebral embolic protection for TAVR Specific design improvements optimize

December 03, 2018Read More

Newslist

Subscribe to our Newsletter

Be the first one to get the latest updates, events and more!

2020
By keyheart41 / July 29, 2020

Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

TAMPA, Fla., July 29, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of...

Read More
keystone heart
2020
By keyheart41 / June 16, 2020

Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

TAMPA, Fla., June 16, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of...

Read More
Keystone Heart
2019
By keyheart41 / January 9, 2019

Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

HANGZHOU, China and CAESAREA, Israel and TAMPA, Florida, Sept. 25, 2018 /PRNewswire/ — Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced it has signed an agreement to acquire Keystone Heart Ltd ...

Read More
Current Cerebral Embolic Protection Landscape
By keyheart41 / December 3, 2018

Current Cerebral Embolic Protection Landscape

Keystone Heart TriGUARD Data Review Jeffrey Moses Conclusions: Overt ...

Read More
REFLECT Clinical Update with TriGUARD3
By keyheart41 / December 3, 2018

REFLECT Clinical Update with TriGUARD3 Cerebral Embolic Protection Device

Tamim Nazif Conclusions: TriGUARD 3 offers complete 3 vessel cerebral ...

Read More
TriGUARD3 Cerebral Embolic Protection Device Case Presentation
By keyheart41 / December 3, 2018

TriGUARD3 Cerebral Embolic Protection Device Case Presentation

Early US Experience Michael Mack Prep Placement Deployment Delivery ...

Read More
TriGUARD3 Cerebral Embolic Protection Device
By keyheart41 / December 3, 2018

TriGUARD3 Cerebral Embolic Protection Device Post-Market EU Registry Plan

Darius Dudek Financial Statement Study Design End-points Other Measure ...

Read More
The Importance of DW-MRI and Longitudinal
By keyheart41 / December 3, 2018

The Importance of DW-MRI and Longitudinal Impact of Cerebral Ischemic Lesions

John Forrest Summary MRI lesions are very frequent after TAVR and are ..

Read More
Current Cerebral Embolic Protection Landscape
2018
By keyheart41 / December 3, 2018

Cerebral Embolic Protection Panel Discussion

Cerebral Embolic Protection Panel Discussion ...

Read More
By keyheart41 / October 2, 2018

Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

Merger Establishes US and EMEA Presence for the Preeminent Chinese Str ...

Read More
Triguard

The Only CE Marked Cerebral Embolic Protection Device Designed to Cover all Three Major Aortic Vessels.

Cerebral Embolic Protection Device

Stay Updated on the latest events from Keystone Heart.

Skip to content